Daniel Pichl - 04 Jan 2025 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Jan 2025, 19:18:34 UTC
Prior SEC filing
20 Feb 2024
Next SEC filing
14 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact

Key filing fact

Daniel Pichl filed Form 4 for SpringWorks Therapeutics, Inc. (SWTX) on 07 Jan 2025.

Key facts

  • This page summarizes Daniel Pichl's Form 4 filing for SpringWorks Therapeutics, Inc. (SWTX).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Jan 2025, 19:18.

Change

  • Previous filing in this sequence was filed on 20 Feb 2024.
  • Current net transaction value: -$278,782.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SWTX transaction

Common Stock

Tax liability

Transaction value
$114,112
Shares
-2,988
Change %
-6.6%
Price
$38.19
Shares after
42,224
Date
04 Jan 2025
Ownership
Direct
Footnotes
F1
SWTX transaction

Common Stock

Tax liability

Transaction value
$96,315
Shares
-2,522
Change %
-6%
Price
$38.19
Shares after
39,702
Date
05 Jan 2025
Ownership
Direct
Footnotes
F1
SWTX transaction

Common Stock

Tax liability

Transaction value
$68,355
Shares
-1,759
Change %
-4.4%
Price
$38.86
Shares after
37,943
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .